论文信息 - Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line Treatment in Advanced Non-Small Cell Lung Cancer - 字舞流文

Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line Treatment in Advanced Non-Small Cell Lung Cancer

Chongqing Tan | Qiao Liu | X. Luo | Liubao Peng | Lidan Yi | X. Wan | Xiaohui Zeng | Sini Li | Shuxia Qin | Liting Wang | Ye Peng | S. Qin | X. Zeng | Xia Luo | X. Luo | Ye Peng | L. Peng